13.07.2015 Views

Abstract Book - Pathology and Laboratory Medicine - University of ...

Abstract Book - Pathology and Laboratory Medicine - University of ...

Abstract Book - Pathology and Laboratory Medicine - University of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ABSTRACT #28CLINICAL SCIENCESGRADUATE STUDENTPOSTER presentationPhenotypic characterization <strong>and</strong> cardiovascular outcomes <strong>of</strong> patients withfamilial hypercholesterolemiaMatt Allard 1 , Michal Martinka, Ahmad Al-Sarraf, Dan Holmes, Jiri Frohlich1Healthy Heart Prevention Clinic, St. Paul's Hospital/ Providence Health CareBackground /objectivesFamilial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by loss-<strong>of</strong>-functionmutations in the low-density lipoprotein (LDL) receptor (LDL-R) or apolipoprotein B-100 (apo B) gene, orgain-<strong>of</strong>-function mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9), resulting in very highblood cholesterol levels <strong>and</strong> premature cardiovascular disease (CVD).To identify <strong>and</strong> phenotypically characterize patients in the Healthy Heart Prevention Clinic with FH todetermine characteristics that increase their risk <strong>of</strong> developing CVD.40MethodsPerform a chart review <strong>of</strong> the FH patients in the Prevention Clinic <strong>and</strong> use <strong>of</strong> the Cardiac Registry to determinewhich patients in this cohort developed CVD (Group 1).ResultsPreliminary work on 354 patients revealed that 72 had evidence <strong>of</strong> CVD. The average age <strong>of</strong> these patients(Group 1) is 69.7 with 58.3% being male. The 282 FH patients not found to have evidence <strong>of</strong> CVD (Group2) have an average age <strong>of</strong> 60.9 with 41.5% being male. Based upon the Dutch Lipid Clinic Network Criteria,90.3% <strong>of</strong> Group 1 was defined as having definite FH compared to 54.6% <strong>of</strong> Group 2. There were some notabledifferences in CV risk factors between the 2 groups. In the patients <strong>of</strong> Group 1 62.5% had a family history <strong>of</strong>premature CVD, 37.5% had history <strong>of</strong> hypertension, <strong>and</strong> 59.7% developed tendon xanthomas. In Group 251.1% had a family history <strong>of</strong> premature CVD, 18.8% had a history <strong>of</strong> hypertension, <strong>and</strong> 35.1% developedtendon xanthomas. Lastly, there is a large difference in the Lp(a) values <strong>of</strong> the two groups with Group 1 having anaverage Lp(a) value <strong>of</strong> 799.4 mg/L <strong>and</strong> Group 2 having an average Lp(a) value <strong>of</strong> 541.1 mg/L.ConclusionsDiagnosis <strong>of</strong> definite FH, older age, presence <strong>of</strong> tendon xanthomas, family history <strong>and</strong> high Lp(a) levels weremuch more prevalent in patients who developed CVD. Identifying these risk factors will allow for earlier <strong>and</strong> moreaggressive management to reduce the risk <strong>of</strong> CVD.2012 * Oral/Poster Presentations

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!